Literature DB >> 16084958

Persistent Yersinia pestis antigens in ischemic tissues of a patient with septicemic plague.

Jeannette Guarner1, Wun-Ju Shieh, May Chu, David C Perlman, Jacob Kool, Kenneth L Gage, Paul Ettestad, Sherif R Zaki.   

Abstract

In November 2002, a couple from New Mexico traveled to New York where both had fever and unilateral inguinal adenopathy. The husband was in septic shock when he sought medical care and was admitted to an intensive care unit, where he developed ischemic necrosis of his feet which later required bilateral amputation. Yersinia pestis was grown from his blood. Immunohistochemical assays using anti-Y pestis antibodies demonstrated multiple bacteria and granular antigens in and around vessels of the ischemic amputation tissues obtained 20 days after initiation of antibiotics; however, no evidence of Y pestis was present in viable tissues. Immunohistochemical evidence of Y pestis inside vessels of gangrenous feet in this patient underscores the importance of adequate excision of necrotic or partially necrotic tissues because antibiotics cannot be effectively delivered to necrotic and poorly perfused tissues.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16084958     DOI: 10.1016/j.humpath.2005.05.016

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  3 in total

Review 1.  An additional step in the transmission of Yersinia pestis?

Authors:  W Ryan Easterday; Kyrre L Kausrud; Bastiaan Star; Lise Heier; Bradd J Haley; Vladimir Ageyev; Rita R Colwell; Nils Chr Stenseth
Journal:  ISME J       Date:  2011-08-11       Impact factor: 10.302

Review 2.  Plague gives surprises in the first decade of the 21st century in the United States and worldwide.

Authors:  Thomas Butler
Journal:  Am J Trop Med Hyg       Date:  2013-09-16       Impact factor: 2.345

3.  Imaging of bubonic plague dynamics by in vivo tracking of bioluminescent Yersinia pestis.

Authors:  Toan Nham; Sofia Filali; Camille Danne; Anne Derbise; Elisabeth Carniel
Journal:  PLoS One       Date:  2012-04-05       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.